Intercept Pharmaceuticals Probability of Future Stock Price Finishing Over 12.24
| ICPTDelisted Stock | USD 10.31 0.16 1.53% |
Intercept |
Intercept Pharmaceuticals Target Price Odds to finish over 12.24
The tendency of Intercept Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 12.24 or more in 90 days |
| 10.31 | 90 days | 12.24 | about 60.49 |
Based on a normal probability distribution, the odds of Intercept Pharmaceuticals to move over $ 12.24 or more in 90 days from now is about 60.49 (This Intercept Pharmaceuticals probability density function shows the probability of Intercept Stock to fall within a particular range of prices over 90 days) . Probability of Intercept Pharmaceuticals price to stay between its current price of $ 10.31 and $ 12.24 at the end of the 90-day period is about 22.41 .
Given the investment horizon of 90 days Intercept Pharmaceuticals has a beta of 0.24. This usually indicates as returns on the market go up, Intercept Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Intercept Pharmaceuticals will be expected to be much smaller as well. Additionally Intercept Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Intercept Pharmaceuticals Price Density |
| Price |
Predictive Modules for Intercept Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Intercept Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Intercept Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Intercept Pharmaceuticals is not an exception. The market had few large corrections towards the Intercept Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Intercept Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Intercept Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.8 | |
β | Beta against Dow Jones | 0.24 | |
σ | Overall volatility | 2.82 | |
Ir | Information ratio | -0.16 |
Intercept Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Intercept Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Intercept Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Intercept Pharmaceuticals is not yet fully synchronised with the market data | |
| Intercept Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Intercept Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 285.71 M. Net Loss for the year was (174.86 M) with profit before overhead, payroll, taxes, and interest of 284.73 M. | |
| Intercept Pharmaceuticals currently holds about 404.78 M in cash with (26.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 81.0% of the company shares are owned by institutional investors |
Intercept Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Intercept Stock often depends not only on the future outlook of the current and potential Intercept Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Intercept Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.8 M | |
| Cash And Short Term Investments | 490.9 M |
Intercept Pharmaceuticals Technical Analysis
Intercept Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Intercept Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Intercept Pharmaceuticals. In general, you should focus on analyzing Intercept Stock price patterns and their correlations with different microeconomic environments and drivers.
Intercept Pharmaceuticals Predictive Forecast Models
Intercept Pharmaceuticals' time-series forecasting models is one of many Intercept Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Intercept Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Intercept Pharmaceuticals
Checking the ongoing alerts about Intercept Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Intercept Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Intercept Pharmaceuticals is not yet fully synchronised with the market data | |
| Intercept Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Intercept Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 285.71 M. Net Loss for the year was (174.86 M) with profit before overhead, payroll, taxes, and interest of 284.73 M. | |
| Intercept Pharmaceuticals currently holds about 404.78 M in cash with (26.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 81.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Intercept Stock
If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |